Akovaz

Name: Akovaz

Side Effects of Akovaz

Serious side effects have been reported with Akovaz. See the “Akovaz Precautions” section.

Common side effects of Akovaz include the following:

  • nausea and vomiting
  • tachycardia
  • palpitations (thumping heart)
  • reactive hypertension
  • bradycardia
  • irregular heartbeat
  • dizziness
  • restlessness

This is not a complete list of Akovaz side effects. Ask your doctor or pharmacist for more information.

Tell your doctor if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Inform MD

Before taking Akovaz, tell your doctor about all of your medical conditions. Especially tell your doctor if you are allergic to Akovaz or to any of its ingredients.

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Akovaz and Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant.

Limited published data on the use of ephedrine sulfate are insufficient to determine a drug associated risk of major birth defects or miscarriage. Animal reproduction studies have not been conducted with Akovaz. Cases of potential metabolic acidosis in newborns at delivery with maternal ephedrine exposure have been reported.
 

Akovaz Usage

Akovaz is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.

Precautions While Using Akovaz

Your doctor will check your progress closely while you are receiving this medicine. This will allow your doctor to see if the medicine is working properly and to check for unwanted effects.

Hypertension (high blood pressure) may occur after receiving this medicine. It is very important that your doctor check your blood pressure after receiving this medicine. If you notice any changes to your normal blood pressure, call your doctor right away.

Using this medicine repeatedly may cause a rapid decrease of response to the drug.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Akovaz Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

Incidence not known
  • Blurred vision
  • dizziness
  • fast, pounding, or irregular heartbeat or pulse
  • headache
  • nervousness
  • pounding in the ears
  • slow or fast heartbeat

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known
  • Nausea or vomiting
  • restlessness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Warnings and Precautions

Pressor Effect with Concomitant Oxytocic Drugs

Serious postpartum hypertension has been described in patients who received both a vasopressor (i.e., methoxamine, phenylephrine, ephedrine) and an oxytocic (i.e., methylergonovine, ergonovine) [see Drug Interactions (7)]. Some of these patients experienced a stroke. Carefully monitor the blood pressure of individuals who have received both ephedrine and an oxytocic.

Tolerance and Tachyphylaxis

Data indicate that repeated administration of ephedrine can result in tachyphylaxis. Clinicians treating anesthesia-induced hypotension with Akovaz (ephedrine sulfate injection) should be aware of the possibility of tachyphylaxis and should be prepared with an alternative pressor to mitigate unacceptable responsiveness.

Risk of Hypertension When Used Prophylactically

When used to prevent hypotension, ephedrine has been associated with an increased incidence of hypertension compared with when ephedrine is used to treat hypotension.

Adverse Reactions

The following adverse reactions associated with the use of ephedrine sulfate were identified in the literature. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.

Gastrointestinal disorders: Nausea, vomiting

Cardiac disorders: Tachycardia, palpitations (thumping heart), reactive hypertension, bradycardia, ventricular ectopics, R-R variability

Nervous system disorders: Dizziness

Psychiatric disorders: Restlessness

Drug Interactions

Interactions that Augment the Pressor Effect
Oxytocin and oxytocic drugs
Clinical Impact:  Serious postpartum hypertension has been described in patients who received both a vasopressor (i.e., methoxamine, phenylephrine, ephedrine) and an oxytocic (i.e., methylergonovine, ergonovine). Some of these patients experienced a stroke.
Intervention:  Carefully monitor the blood pressure of individuals who have received both ephedrine and an oxytocic.
Clonidine, propofol, monoamine oxidase inhibitors (MAOIs), atropine
Clinical Impact:  These drugs augment the pressor effect of ephedrine.
Intervention:  Carefully monitor the blood pressure of individuals who have received both ephedrine and any of these drugs.
Interactions that Antagonize the Pressor Effect
Clinical Impact:  These drugs antagonize the pressor effect of ephedrine.
Intervention:  Carefully monitor the blood pressure of individuals who have received both ephedrine and any of these drugs.
Examples:  α-adrenergic antagonists, β-adrenergic receptor antagonists, reserpine, quinidine, mephentermine
Other Drug Interactions
Guanethidine
Clinical Impact:  Ephedrine may inhibit the neuron blockage produced by guanethidine, resulting in loss of antihypertensive effectiveness.
Intervention:  Clinician should monitor patient for blood pressor response and adjust the dosage or choice of pressor accordingly.
Rocuronium
Clinical Impact:  Ephedrine may reduce the onset time of neuromuscular blockade when used for intubation with rocuronium if administered simultaneously with anesthetic induction.
Intervention:  Be aware of this potential interaction. No treatment or other interventions are needed.
Epidural anesthesia
Clinical Impact:  Ephedrine may decrease the efficacy of epidural blockade by hastening the regression of sensory analgesia.
Intervention:  Monitor and treat the patient according to clinical practice.
Theophylline
Clinical Impact:  Concomitant use of ephedrine may increase the frequency of nausea, nervousness, and insomnia.
Intervention:  Monitor patient for worsening symptoms and manage symptoms according to clinical practice.
Cardiac glycosides
Clinical Impact:  Giving ephedrine with a cardiac glycoside, such as digitalis, may increase the possibility of arrhythmias.
Intervention:  Carefully monitor patients on cardiac glycosides who are also administered ephedrine.

How Supplied/Storage and Handling

Akovaz (ephedrine sulfate injection), 50 mg/mL, is supplied as follows:

NDC Strength How Supplied
76014-005-25 50 mg/mL 1 mL clear glass vial; for single use (supplied in packages of 25)

Vial stoppers are not manufactured with natural rubber latex. Store Akovaz (ephedrine sulfate injection), 50 mg/mL, at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in carton until time of use. For single use only. Discard unused portion.


Manufactured for:

Avadel

Avadel Legacy Pharmaceuticals, LLC

Chesterfield, MO 63005


Rev. 04/17


(web3)